What "Adequate" Actually Means: How US Law Puts Cosmetic Safety on the Company, Not the FDA
What evidence a US cosmetic must have behind it and why 'FDA approved' on a jar is a red flag.
A reading desk built on a working Buffalo beauty catalogue: what the products are, what they cost, and where they are stocked.
Say what a US cosmetics maker is legally required to file, and what a listed product still has not been checked for.
22 catalogue entries sit in this section.
Written for this desk.
About 5 minutes.
Under the Modernization of Cosmetics Regulation Act of 2022, a small beauty brand must now file its facility registration and list every marketed product with the Food and Drug Administration. A product listing, however, signals only that a responsible person submitted required information—not that FDA has reviewed, tested, or approved the cosmetic. The gap between paperwork and scrutiny is where many buyers and sellers misunderstand what they are seeing on a label.
MoCRA imposes two distinct filing requirements on cosmetic manufacturers and processors. First, facilities must register with FDA, update that registration within 60 days of any changes, and renew it every two years. Second, a responsible person must list each marketed cosmetic product with FDA, include the product's ingredients, and provide annual updates to that listing. These obligations apply to the paperwork behind every jar, bottle, and tube that meets the statutory definition of a cosmetic.
FDA maintains a single portal for both registration and listing, and the agency treats these submissions as information-gathering exercises required by law. The forms capture facility identifiers, product categories, ingredient lists, and contact information for the responsible person. A brand cannot substitute one filing for the other: facility registration covers where products are made or processed, while product listing covers what is actually being sold.
The identity of who must file matters because FDA does not automatically assign responsibility to the brand owner in every business structure. Under MoCRA, the "responsible person" is the manufacturer, packer, or distributor whose name appears on the product label under section 609(a) of the Federal Food, Drug, and Cosmetic Act or section 4(a) of the Fair Packaging and Labeling Act. This means the name on the jar determines who bears the legal duty to list the product and keep that listing current.
A contract manufacturer might appear on the label of one product line, while the brand's own company appears on another. A distributor that puts its name on a repackaged serum becomes the responsible person for that listing, even if the formulation originated elsewhere. The label, not the supply chain arrangement, controls the filing obligation. FDA's Form FDA 5067, used for cosmetic product listing, includes fields for the responsible person's name and contact information, along with product categories and the facility identifiers where manufacturing or processing occurs. If a facility is exempt from registration, the form permits the use of the facility name and address in place of a registration number.
MoCRA does provide certain small businesses with exemptions from facility registration and product listing, but the exemption is narrower than many assume. FDA has carved out specific product categories that lose protection regardless of the company's size. The exemptions do not apply to facilities or responsible persons handling products that regularly come into contact with the eye's mucus membrane under customary use. Eye creams, serums applied near the lash line, and certain makeup removers fall outside the exemption.
Injected products forfeit exemption status automatically. So do products intended for internal use, which covers ingestible cosmetics and some oral care items marketed with cosmetic claims. Finally, the exemption disappears for products intended to alter appearance for more than 24 hours under customary conditions of use when consumer removal is not part of those conditions. This last category captures certain long-wear makeup, semi-permanent brow tints, and similar formulations. A brand that makes only moisturizers and cleansers might qualify for exemption; one that adds a lash serum or overnight lip mask likely does not.
What exactly does a product listing contain? According to FDA's registration and listing guidance, the submission includes the responsible person's name and contact information, the product category, a complete ingredient list, and facility identifiers showing where the product is manufactured or processed. The Form FDA 5067 template includes a checkbox indicating whether the submission is for a small business, allowing FDA to track exemption claims against actual product categories.
Annual updates are mandatory. If a brand reformulates a listed product—swapping a preservative, adjusting a fragrance component, or changing a color additive—the responsible person must update the listing to reflect the new ingredient profile. The system is designed to create a current snapshot of what is on the market, not a historical record of past formulations. For small-batch brands that tweak recipes based on seasonal ingredient availability or customer feedback, this creates ongoing administrative work that scales with product variety rather than production volume.
The existence of a product listing in FDA's database carries a specific legal meaning that is frequently misread. FDA's registration and listing page states explicitly that the existence of a product listing is not the same thing as FDA approval. Listing is an information submission required by law, not a premarket review. The agency does not evaluate the safety of ingredients, the accuracy of claims, or the quality of manufacturing before a listing goes into the database.
This distinction matters for consumer understanding. A buyer who sees a product described as "FDA-listed" may reasonably assume some level of regulatory vetting has occurred. In fact, the brand has simply disclosed what it contains and who made it. Safety responsibility remains with the manufacturer and the responsible person, subject to FDA's post-market authority to inspect facilities, examine records, and take action against adulterated or misbranded products. The listing itself proves compliance with a paperwork requirement, not a product quality determination.
The registration and listing framework sits inside a larger expansion of FDA authority over cosmetics that MoCRA enacted. The statute also grants FDA new power to issue good manufacturing practice regulations for cosmetics, which will eventually impose facility standards beyond the current registration requirement. This means the paperwork obligations described here are the opening phase of a more comprehensive regulatory regime.
For small beauty brands, the practical effect is a new layer of administrative compliance that parallels what drug and device manufacturers have long faced, but without the premarket approval gateway that those industries know. A maker of twenty SKUs must now maintain twenty annual listings, tied to facility registrations that renew every two years, with trigger points for updates scattered across the calendar. The burden is manageable for organized operations and potentially crushing for one-person shops juggling formulation, marketing, and fulfillment.
The law makes a small brand disclose who it is and what it sells. It does not make FDA vouch for what is inside the jar.
Median here is $11.99 against $24.99 across the whole catalogue. 2 entries are listed at $0: counted in the first band, not named above.
What evidence a US cosmetic must have behind it and why 'FDA approved' on a jar is a red flag.
Which chemical classes a state has removed from cosmetics and when the deadlines fell.
Name the ingredient classes California removed and the dates they stopped being legal to sell.
Tell which of the three claims is certified by someone and which is a marketing word.
What the figures come from. Every product name, price, stock state and photograph on this site is taken from the brand’s own product records. Where a record is silent, the field is left off the page rather than filled in.
What the articles rest on. Each piece names the statute, the agency rule or the labeling standard it describes, and stays inside it. Figures, dates and thresholds are the ones in those documents.
What is not done here. Nothing in this catalogue is bought, sampled or tested by the desk. No product is scored or ranked against another, no placement is sold inside an article, and nothing on these pages is medical advice.
This page: September 27, 2026
This site keeps only what it needs to remember this choice and to serve pages. No advertising or profiling cookies are set. See the cookie note and the privacy policy.